[Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review].
Ter Arkh
; 94(11): 1326-1332, 2022 Dec 26.
Article
in Russian
| MEDLINE | ID: covidwho-20239066
ABSTRACT
The hepatic consequences of SARS-CoV-2 infection are now recognized as an important component of CoronaVIrus Disease 2019 (COVID-19). This aspect is most clinically relevant in patients with pre-existing chronic liver disease (CKD), who are at extremely high risk of severe COVID-19 and death. Risk factors for severe CKD, especially in people with liver cirrhosis and non-alcoholic fatty liver disease, are the direct and indirect cytotoxic effects of coronavirus against the background of systemic inflammation, blood clotting disorders and immune dysfunction. The severe negative impact of the pandemic in the presence of CKD and the difficulties of patient relationships contribute to the progressive increase in the global burden of liver disease on the health system.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Renal Insufficiency, Chronic
/
Non-alcoholic Fatty Liver Disease
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Humans
Language:
Russian
Journal:
Ter Arkh
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS